NAFDAC urges Nigerian patent medicine dealers to stop selling counterfeit drugs due to health risks.

NAFDAC, Nigeria's food and drug regulatory agency, has urged patent medicine dealers to cease the sale of substandard and counterfeit drugs, highlighting the serious health risks they pose. Director-General Prof. Mojisola Adeyeye emphasized the need for genuine products and compliance with regulations, prioritizing public welfare over profit. The agency's campaign aims to reduce counterfeit medicines and enhance community health by encouraging collaboration among stakeholders in drug regulation.

September 30, 2024
3 Articles

Further Reading